Here's all you need to know ahead of Malpani Pipes And Fittings IPO allotment; check allotment date, steps to check allotment status, listing date and more. Malpani Pipes And Fittings IPO Allotment ...

Dr Agarwal Healthcare IPO allotment status : The Dr Agarwal Healthcare IPO share allotment will be finalised on Monday, February 3. Investors who applied for the Dr Agarwals IPO can check the Dr ...

And Anduril founder Palmer Luckey says this defense technology stock is "on a path to" IPO. Anduril could be the next Palantir -- in more ways than one. Attention, defense investors! In case you ...

The company will finalise the IPO share allotment by February 3, and the trading in Malpani Pipes shares will commence on the BSE SME effective February 5. Meanwhile, the funds raised via IPO will ...

US-based Metsera has set its sights on a $289m public listing as the weight loss drug developer becomes one of the early biotechs to venture into the thawing IPO landscape in 2025. Metsera is ...

Metsera (MTSR), which is developing ultra-long-acting drugs for the treatment of obesity, has set terms for an upsized $275M initial public offering. In a recent SEC filing, Metsera (MTSR) said it ...

(Reuters) -Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S. IPO, aiming to capitalize on Wall Street's insatiable ...

Maze seeks as much as $133 mln in New York IPO Backers include Alphabet's GV and Third Rock Ventures Biotech IPOs set for ramp up in coming weeks Jan 27 (Reuters) - Drug developer Maze ...

Metsera seeks to raise up to $292.2 million in US IPO Venture capital firm ARCH Ventures founded Metsera in 2022 Jan 27 (Reuters) - Metsera, which is developing weight-loss drugs, said on Monday ...

Obesity drug developer Aardvark Therapeutics (AARD ... More on Renaissance Capital Greenwich Funds - Renaissance IPO ETF IPO: Favorable Capital Markets In 2025 Not Yet A Tailwind (Rating Downgrade ...